MATRIX PROTEINS OF ENVELOPED VIRUSES
MATRIX PROTEINS OF ENVELOPED VIRUSES
批准号:
3131869
负责人:
ROBERT R WAGNER
金额:
$11.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-01-01 至 1987-12-31
关键词:
Vesiculovirus calorimetry circular dichroism conformation fluorescence polarization gel electrophoresis genetic manipulation genetic recombination genetic translation membrane lipids membrane structure molecular cloning monoclonal antibody peptides phospholipids temperature sensitive mutant virus assembly virus envelope virus infection mechanism
中文摘要
负链病毒的外周基质(M)蛋白,如
水疱性口炎病毒(VSV)在病毒粒子组装和转录过程中起关键作用。
转录调控。我们建议对分子基础进行表征
对于膜结合、核衣壳结合,以及
VSV M蛋白通过下列途径发挥转录抑制功能
化学、免疫学、遗传学和生物物理方法:
1.用特定的化学物质和蛋白酶裂解产生的多肽
将与合成的寡肽一起进行测序、测绘和测试,
它们与磷脂小泡和核衣壳结合的能力,以及
来抑制病毒转录。
2.制备了M蛋白的单抗,并对其进行了检测
它们与特定多肽的反应性和它们的能力
抑制M蛋白及其多肽的各种生物学功能。
3.互补III组温度敏感突变M蛋白,
受到转录抑制的限制,突变的M蛋白将被
测试它们与脂泡、核衣壳和
特异性的单抗。
4.突变型、突变型和野生型M蛋白的重组DNA克隆
将准备基因并对它们的cDNA进行测序,以确定
M蛋白与囊泡和核衣壳结合缺陷的病变和
在转录抑制中。我们最终希望能制备出人的cdna克隆
在表达载体中插入M基因,形成定点缺陷的M蛋白。
5.野生型和突变型M蛋白的生物物理研究
多肽将被用来分析膜动力学的扰动
通过与膜反应的荧光去偏振来测量
由圆二色光谱测定。
6.VSV-New Jersey和A/WSN/33流感病毒M蛋白及其相互作用
单抗也将通过这些方法进行检测以进行比较。
与M蛋白在功能和进化上的相关性
VSV-印第安纳州。
英文摘要
The peripheral matrix (M) protein of negative-strand viruses, such as
vesicular stomatitis virus (VSV), plays a key role in virion assembly and
transcription regulation. We propose to characterize the molecular basis
for the membrane binding, nucleocapsid binding, and
transcription-inhibition functions of the VSV M protein by the following
chemical, immunological, genetic, and biophysical methods:
1. Peptides generated by cleavage with specific chemicals and proteases
will be sequenced, mapped, and tested, along with synthetic oligopeptides,
for their capacity to bind to phospholipid vesicles and nucleocapsids, and
to inhibit viral transcription.
2. Monoclonal antibodies to M protein have been prepared and will be tested
for their reactivity with specific peptides and for their capacity to
inhibit the various biological functions of M protein and its peptides.
3. Complementation group III temperature-sensitive mutant M proteins,
restricted in transcription-inhibition, and revertant M proteins will be
tested for their capacity to bind to lipid vesicles, nucleocapsids, and
specific monoclonal antibodies.
4. Recombinant DNA clones of mutant, revertant, and wild-type M-protein
genes will be prepared and their cDNAs sequenced to identify the sites of
lesions in M proteins defective in binding to vesicles and nucleocapsid and
in transcription-inhibition. We eventually hope to prepare cDNA clones of
M genes in expression vectors to make site-directed defective M proteins.
5. Biophysical studies with wild-type and mutant M proteins and their
peptides will be performed to assay perturbations of membrane dynamics
measured by fluorescence depolarization reacting with membranes as
determined by circular dichroism spectroscopy.
6. M proteins of VSV-New Jersey and A/WSN/33 influenza virus and their
monoclonal antibodies will also be examined by these methods for comparison
with the functional and evolutionary relatedness of the M protein of
VSV-Indiana.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--DEVELOPMENT FUNDS
-
批准号:6618868
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2002
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6501444
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2001
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6352735
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2000
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6311505
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2000
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6216467
-
项目类别:
-
资助金额:$15.27万
-
财政年份:1999
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6102360
-
项目类别:
-
资助金额:$15.27万
-
财政年份:1998
-
负责人:ROBERT R WAGNER
-
依托单位:
CORE--DEVELOPMENT FUNDS
-
批准号:6236881
-
项目类别:
-
资助金额:$15.21万
-
财政年份:1997
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101826
-
项目类别:
-
资助金额:$23.95万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101827
-
项目类别:
-
资助金额:$72.19万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101825
-
项目类别:
-
资助金额:$64.28万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:2091519
-
项目类别:
-
资助金额:$66.56万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101823
-
项目类别:
-
资助金额:$74.1万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101828
-
项目类别:
-
资助金额:$70.26万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
CANCER RESEARCH CENTER
-
批准号:3101829
-
项目类别:
-
资助金额:$91.06万
-
财政年份:1987
-
负责人:ROBERT R WAGNER
-
依托单位:
MATRIX PROTEINS OF ENVELOPED VIRUSES
-
批准号:3131867
-
项目类别:
-
资助金额:$10.3万
-
财政年份:1985
-
负责人:ROBERT R WAGNER
-
依托单位:
MATRIX PROTEINS OF ENVELOPED VIRUSES
-
批准号:3131870
-
项目类别:
-
资助金额:$11.02万
-
财政年份:1985
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:3480580
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:2059765
-
项目类别:
-
资助金额:$33.11万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:2059764
-
项目类别:
-
资助金额:$31.86万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
CELLULAR RESISTANCE TO VIRAL INFECTION
-
批准号:3124891
-
项目类别:
-
资助金额:$29.02万
-
财政年份:1978
-
负责人:ROBERT R WAGNER
-
依托单位:
海外基金